Corporate Capabilities - - BioPharm International

ADVERTISEMENT

Corporate Capabilities

BioPharm International

This is the annual profile of the industry's companies, their history, expertise, and biopharmaceutical products, equipment, and services. The 2002 issue in December will be the MegaSource -- a combination of corporate capabilities, buyers guide, and editorial index. The MegaSource will provide BioPharm's readers with a unique and indispensable, year-round resource to find information on this industry's major suppliers, and offer a reference to the peer-reviewed articles BioPharm has produced.
blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
AbbVie's Acquisition of Shire Could Save $8 Billion in Taxes
July 21, 2014
AstraZeneca Reveals Design for New Global R&D Center and Corporate Headquarters
July 18, 2014
AbbVie to Acquire Shire for $54.7 Billion
July 18, 2014
Particulate Matter Prompts Baxter's Recall of IV Solutions
July 17, 2014
Author Guidelines
Source: BioPharm International,
Click here